[Correction of hemodynamic and metabolic disorders in patients with ischemic heart disease].
Bondarenko
I P
IP
D000368:Aged; D000369:Aged, 80 and over; D045930:Anabolic Agents / Q000009:adverse effects / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy* / Q000503:physiopathology; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004963:Estrenes / Q000009:adverse effects / Q000627:therapeutic use; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D014297:Trimethylsilyl Compounds / Q000009:adverse effects / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use; D014748:Vinca Alkaloids / Q000627:therapeutic use
D045930:Anabolic Agents; D004963:Estrenes; D014297:Trimethylsilyl Compounds; D014665:Vasodilator Agents; D014748:Vinca Alkaloids; C013983:vinpocetine; C050044:silabolin
Korrektsiia gemodinamicheskikh i metabolicheskikh narusheniĭ u bol'nykh ishemicheskoĭ bolezn'iu serdtsa.